Impel NeuroPharma will be attending the International Headache Congress (IHC) 2019 annual meeting. The team will present data from the INP104 clinical program.

The Impel team is attending the American Headache Society’s (AHS) annual meeting. We will be presenting new data on our INP104 migraine program.

Dr. Greg Davis will be presenting on Impel’s behalf at Rhinoworld 2019 in Chicago, IL on The Quantitative Scoring Scale – Nasal Mucosa (QSS-NM): A scale proposed for assessing olfactory mucosa changes following drug administration to the upper nasal space…